Multidrug-Resistant Tuberculosis in Central Asia and Predominant Beijing Lineage, Challenges in Diagnosis, Treatment Barriers, and Infection Control Strategies: An Integrative Review
<b>Background</b>: Multidrug-resistant tuberculosis (MDR-TB) remains a significant public health threat in Central Asia, where rising resistance to first-line anti-TB drugs challenges control efforts. As of 2024, the World Health Organization (WHO) reports that over 2.5% of new TB cases...
Saved in:
| Main Authors: | Ulan Kozhamkulov, Sholpan Iglikova, Anar Rakisheva, Joseph Almazan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/14/7/673 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HYLOGEOGRAPHY OF THE BEIJING LINEAGE IN MONGOLIA
by: E. A. Orlova, et al.
Published: (2016-09-01) -
Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01) -
Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01) -
Epidemiological changes in tuberculosis and genotyping characteristics of Mycobacterium Tuberculosis in Ningxia, China
by: Guangtian Liu, et al.
Published: (2025-06-01) -
Discrepancy in the transmissibility of multidrug-resistant mycobacterium tuberculosis in urban and rural areas in China
by: Meng Li, et al.
Published: (2023-12-01)